Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Carlsmed (CARL) Enterprise Value (2024 - 2026)

Carlsmed filings provide 2 years of Enterprise Value readings, the most recent being -$110.0 million for Q4 2025.

  • On a quarterly basis, Enterprise Value fell 173.46% to -$110.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$110.0 million, a 173.46% decrease, with the full-year FY2025 number at -$110.0 million, down 173.46% from a year prior.
  • Enterprise Value hit -$110.0 million in Q4 2025 for Carlsmed, up from -$115.5 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$33.6 million in Q2 2025 to a low of -$115.5 million in Q3 2025.